Owolabi Ogunneye , MDFRCP(UK)
Internal Medicine - Nephrology • Flint, MI
2486 Nerredia St E
Flint, MI 485324807
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Owolabi Ogunneye is listed in NPPES under Internal Medicine - Nephrology.
-
NPI assigned on August 23, 2010; this date does not establish years in practice.
-
Published CMS data list 1,653 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99232 — Subsequent hospital care with moderate levelof medical decision making: 704 service units.
- 99233 — Subsequent hospital care with moderate levelof medical decision making: 192 service units.
- 90960 — Dialysis services, 4 or more physician visits per month (20 years or older): 137 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 15 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,917 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ozempic (Semaglutide) — 250 prescription fills, including refills.
- Carvedilol — 183 prescription fills, including refills.
- Jardiance (Empagliflozin) — 176 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 56 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Internal Medicine - Nephrology in Flint, MI (2024, 15 clinicians with data). Median for this group: 1,766. Middle half: 1,289 to 1,925.
More Medicare Part B services than 70% of clinicians listed under Internal Medicine - Nephrology in Michigan (2024, 269 clinicians with data). Median for this group: 1,027. Middle half: 464 to 1,839.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,066 in 2020 to 1,653 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
2486 Nerredia St E
Flint, MI 485324807
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Kidney Disease And Hypertension Consultants Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2004
What Public CMS Data Show
Internal Medicine - Nephrology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
459 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $203,815 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $159,866 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
5,865 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$880,793 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $883.70 across 32 records.
By nature of payment
- Food and Beverage: $883.70 across 32 records.
Reporting-company totals (3 largest of 11)
- Apellis Pharmaceuticals, Inc.: $158.68 across 3 records.
- Calliditas Therapeutics US Inc.: $121.42 across 5 records.
- Recor Medical Inc: $114.56 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
22 years (graduated 2004)
CMS Doctors and Clinicians data list 2004 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2010
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Owolabi Ogunneye has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Owolabi Ogunneye as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Flint and Michigan
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Internal Medicine - Nephrology in Flint, MI (2024, 15 clinicians with data). Median for this group: 1,766. Middle half: 1,289 to 1,925.
More Medicare Part B services than 70% of clinicians listed under Internal Medicine - Nephrology in Michigan (2024, 269 clinicians with data). Median for this group: 1,027. Middle half: 464 to 1,839.
Medicare-allowed amount
Close to the middle for clinicians listed under Internal Medicine - Nephrology in Flint, MI (2024, 15 clinicians with data). Median for this group: $221,131. Middle half: $172,225 to $262,155.
A higher Medicare-allowed amount than 75% of clinicians listed under Internal Medicine - Nephrology in Michigan (2024, 269 clinicians with data). Median for this group: $132,750. Middle half: $52,672 to $203,815.
Paid by Medicare
Close to the middle for clinicians listed under Internal Medicine - Nephrology in Flint, MI (2024, 15 clinicians with data). Median for this group: $171,389. Middle half: $132,107 to $201,993.
A higher Medicare payment amount than 75% of clinicians listed under Internal Medicine - Nephrology in Michigan (2024, 269 clinicians with data). Median for this group: $103,770. Middle half: $40,261 to $159,249.
Medicare Part D prescriptions
More Part D prescriptions than 60% of clinicians listed under Internal Medicine - Nephrology in Flint, MI (2024, 15 clinicians with data). Median for this group: 2,614. Middle half: 1,887 to 3,220.
More Part D prescriptions than 90% of clinicians listed under Internal Medicine - Nephrology in Michigan (2024, 282 clinicians with data). Median for this group: 793. Middle half: 339 to 1,456.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Internal Medicine - Nephrology in Flint, MI (2024, 15 clinicians with data). Median for this group: $247,399. Middle half: $176,824 to $738,618.
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine - Nephrology in Michigan (2024, 282 clinicians with data). Median for this group: $95,824. Middle half: $34,792 to $239,878.
15 active clinicians are listed under Internal Medicine - Nephrology with a practice address in Flint, MI (376 in Michigan).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Flint
73.3% of these 15 clinicians have the CMS telehealth indicator.
100% of these 15 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 46% from 3,066 in 2020 to 1,653 in 2024.
- 2020: 3,066
- 2021: 3,205
- 2022: 2,694
- 2023: 2,271
- 2024: 1,653
-
Medicare-allowed amount
Medicare-allowed amount decreased 48% from $388,319 in 2020 to $203,815 in 2024.
- 2020: $388,319
- 2021: $421,305
- 2022: $364,338
- 2023: $316,157
- 2024: $203,815
-
Paid by Medicare
Paid by Medicare decreased 48% from $307,589 in 2020 to $159,866 in 2024.
- 2020: $307,589
- 2021: $333,668
- 2022: $286,351
- 2023: $250,037
- 2024: $159,866
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 13% from 2,583 in 2020 to 2,917 in 2024.
- 2020: 2,583
- 2021: 2,508
- 2022: 2,784
- 2023: 2,721
- 2024: 2,917
-
30-day fills
30-day fills increased 16% from 5,077 in 2020 to 5,865 in 2024.
- 2020: 5,077
- 2021: 5,014
- 2022: 5,738
- 2023: 5,895
- 2024: 5,865
-
Part D drug cost
Part D drug cost increased 788% from $99,173 in 2020 to $880,793 in 2024.
- 2020: $99,173
- 2021: $146,297
- 2022: $254,608
- 2023: $703,660
- 2024: $880,793
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 47% from $1,677.52 in 2021 to $883.70 in 2025.
- 2021: $1,677.52
- 2022: $258.26
- 2023: $324.24
- 2024: $605.85
- 2025: $883.70
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 32 records totaling $883.70.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Empaveli | General | $120.34 |
| Recor Medical Inc |
Food and Beverage
Cash or cash equivalent
|
Paradise Ultrasound Renal Denervation System | General | $93.72 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $30.61 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $30.51 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $29.92 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
— | General | $28.56 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $28.12 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
JYNARQUE | General | $27.13 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
— | General | $26.89 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $26.51 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $25.26 |
| SCPHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
FUROSCIX | General | $23.83 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
JYNARQUE | General | $23.63 |
| SCPHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
FUROSCIX | General | $22.67 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $22.23 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
— | General | $21.97 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $21.89 |
| SCPHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
FUROSCIX | General | $21.47 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $21.10 |
| Recor Medical Inc |
Food and Beverage
Cash or cash equivalent
|
Paradise Ultrasound Renal Denervation System | General | $20.84 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $20.46 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $20.31 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $20.17 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Empaveli | General | $20.04 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Empaveli | General | $18.30 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
704 | 236 | $120.00 | $75.20 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
192 | 99 | $160.00 | $113.11 |
|
90960
Dialysis services, 4 or more physician visits per month (20 years or older)
|
137 | 33 | $600.00 | $338.93 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
131 | 116 | $175.00 | $114.14 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
108 | 91 | $25.00 | $15.75 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
92 | 85 | $180.00 | $124.62 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
67 | 58 | $190.00 | $151.25 |
|
90966
Home dialysis services per month (20 years or older)
|
55 | 12 | $550.00 | $285.83 |
|
90961
Dialysis services, 2-3 physician visits per month (20 years or older)
|
42 | 25 | $500.00 | $281.50 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
38 | 36 | $270.00 | $165.10 |
|
90962
Dialysis services, 1 physician visit per month (20 years or older)
|
20 | 12 | $400.00 | $195.19 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
18 | 18 | $150.00 | $101.09 |
|
90935
Hemodialysis procedure with physician evaluation
|
17 | 17 | $125.00 | $67.30 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
17 | 16 | $110.00 | $82.21 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
15 | 15 | $220.00 | $159.27 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ozempic | Semaglutide | 250 | 8,560 | $270,505.46 | 73 |
| Carvedilol | Carvedilol | 183 | 12,868 | $2,001.05 | 67 |
| Jardiance | Empagliflozin | 176 | 10,501 | $195,663.99 | 58 |
| Nifedipine Er | Nifedipine | 154 | 10,198 | $5,191.30 | 53 |
| Losartan Potassium | Losartan Potassium | 132 | 9,518 | $1,233.90 | 52 |
| Allopurinol | Allopurinol | 120 | 10,260 | $1,338.38 | 57 |
| Amlodipine Besylate | Amlodipine Besylate | 118 | 7,576 | $932.41 | 43 |
| Mounjaro | Tirzepatide | 104 | 3,500 | $126,856.22 | 27 |
| Furosemide | Furosemide | 95 | 7,710 | $598.43 | 47 |
| Lisinopril | Lisinopril | 92 | 6,753 | $694.55 | 38 |
| Potassium Chloride | Potassium Chloride | 91 | 7,005 | $2,968.90 | 43 |
| Trulicity | Dulaglutide | 91 | 2,772 | $91,722.68 | 23 |
| Calcitriol | Calcitriol | 89 | 6,424 | $2,162.94 | 42 |
| Hydralazine Hcl | Hydralazine Hcl | 87 | 5,899 | $1,364.84 | 38 |
| Spironolactone | Spironolactone | 72 | 5,460 | $936.72 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 68 | 4,294 | $303.35 | 26 |
| Calcium Acetate | Calcium Acetate | 66 | 3,522 | $6,501.27 | 26 |
| Farxiga | Dapagliflozin Propanediol | 65 | 3,820 | $71,449.10 | 26 |
| Bumetanide | Bumetanide | 60 | 4,362 | $2,506.46 | 27 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 49 | 187 | $116.01 | 46 |
| Lokelma | Sodium Zirconium Cyclosilicate | 48 | 2,147 | $23,918.40 | 25 |
| Metoprolol Succinate | Metoprolol Succinate | 45 | 3,774 | $1,001.53 | 24 |
| Tamsulosin Hcl | Tamsulosin Hcl | 44 | 2,961 | $681.68 | 17 |
| Potassium Citrate Er | Potassium Citrate | 40 | 3,060 | $2,079.85 | 19 |
| Famotidine | Famotidine | 34 | 1,262 | $314.11 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEPHROLOGY
I20150811005358
MI
0941432827
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Kidney Disease And Hypertension Consultants Pc
2486 Nerredia St, Flint, MI 485324807
Kidney Disease And Hypertension Consultants Pc
2486 Nerredia St, Flint, MI 485324807
Phone: 8102309901
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Nurse Practitioner
Internal Medicine
Nurse Practitioner - Adult Health
Doctor of Nursing Practice, Adult Nurse Practitioner, Nurse Practitioner (Certified)
Nurse Practitioner - Primary Care
Family Nurse Practitioner (Certified)
Specialist
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.), Master of Public Health
Career & Practice History
NPI enumerated August 23, 2010.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Internal Medicine - Nephrology Specialists in Flint
- Dr. Ali Owda, MD
- Dr. Mohamed Abdalla, MD
- Dr. Sundar Ramanathan, MD
- Dr. Senthil Ramaiyah, MD
- Dr. Vaibhav Sahni, MD
- Dr. Aniruddha Palya, MD, MPH
Mailing Address
2486 Nerredia St E
Flint, MI 485324807
Phone: 8102309901